GRM5 and Huntington disease: The observation that this molecular pathway is similarly activated in a zQ175 mouse model of HD following treatment with the mGluR5 NAM, CTEP [14], indicates that mGluR5 contributes neurodegenerative disease processes via a conserved mechanism.